Obinutuzumab (GAZYVA), a Potent Anti-B Cell Agent, in the Treatment of Rituximab-Unresponsive IgM Anti-Myelin-Associated-Glycoprotein (MAG)-Mediated-Neuropathy-MedSci.cn

Obinutuzumab (GAZYVA), a Potent Anti-B Cell Agent, in the Treatment of Rituximab-Unresponsive IgM Anti-Myelin-Associated-Glycoprotein (MAG)-Mediated-Neuropathy

Rakocevic, G; Outschoorn, UM; Dalakas, M

NEUROLOGY, 2018; 90 ():

科室
- - 订阅+
  - 更多科室
工具
服务